These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8092154)

  • 61. The future of drug product selection in health care and the role of the pharmacy and therapeutics committee.
    Cohen P
    Manag Care Interface; 2006 Dec; 19(12):15-6. PubMed ID: 17274477
    [No Abstract]   [Full Text] [Related]  

  • 62. Adverse drug reactions and the P & T committee.
    Lipman AG
    Hosp Formul; 1980 Jul; 15(7):580. PubMed ID: 10247654
    [No Abstract]   [Full Text] [Related]  

  • 63. [Pharmacotherapy--how to raise the standard?].
    Naess K
    Nord Med; 1972 Mar; 87(3):78-80. PubMed ID: 5027852
    [No Abstract]   [Full Text] [Related]  

  • 64. Achieving rational therapeutics through consensus-based protocols and follow-up.
    Quintiliani R; Gousse GC; Chow MS
    Hosp Formul; 1990 Mar; 25(3):283-4, 289-94. PubMed ID: 10103836
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Use of 0.9% sodium chloride injection without heparin for maintaining indwelling intermittent injection sites.
    Clin Pharm; 1985; 4(5):488-9. PubMed ID: 4053520
    [No Abstract]   [Full Text] [Related]  

  • 66. The military health services system model for pharmacoeconomic decision making.
    Ries AJ; Potyk RP; Brier KL; Miller MR; Tornow JJ; Weber MP; Finder SF; Reeves CS
    Med Interface; 1995 May; 8(5):132-7. PubMed ID: 10142786
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Approval of drugs by national and European agencies--from the viewpoint of drug approval committee A].
    Henschler D
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):600-3. PubMed ID: 9527449
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Choice of drugs--by whom, for whom and to what costs?].
    Frisk M; Strömstedt A
    Lakartidningen; 2000 Sep; 97(39):4343-6. PubMed ID: 11076479
    [No Abstract]   [Full Text] [Related]  

  • 69. [Pharmacotherapeutic information explosion and medical practice].
    Dahlström H
    Lakartidningen; 1972 Sep; 69(40):4512-4. PubMed ID: 5072438
    [No Abstract]   [Full Text] [Related]  

  • 70. Reducing the risks of infiltration and extravasation.
    Rosenthal K
    Nursing; 2007; 37 Suppl Med():4-8. PubMed ID: 18163033
    [No Abstract]   [Full Text] [Related]  

  • 71. The infected peripheral intravenous catheter: a degree of ignorance, neglect and indifference.
    Cozanitis D; Mäkelä P
    Acta Anaesthesiol Belg; 2008; 59(2):59-63. PubMed ID: 18652101
    [No Abstract]   [Full Text] [Related]  

  • 72. P & T Committee interview: Promoting rational drug use.
    Hunt TK; Herfindal ET
    Hosp Formul; 1988 Apr; 23(4):359-62, 365-6, 369. PubMed ID: 10286839
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Revised ADR report permits internal review of drug experience.
    Jeffrey LP
    Pharm Times; 1986 Dec; 52(12):48-50. PubMed ID: 10317827
    [No Abstract]   [Full Text] [Related]  

  • 74. The Drug Spotlight Program.
    Aagaard GN
    J Assoc Hosp Med Educ; 1978; 1st Quarter():58-60. PubMed ID: 10307276
    [No Abstract]   [Full Text] [Related]  

  • 75. The goals and functions of a P & T committee.
    Sudds TW; Williams RR
    Hosp Formul; 1985 Nov; 20(11):1163-5, 1171, 1174. PubMed ID: 10274572
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Pharmacy committees and the prescription of drugs].
    Boréus LO
    Lakartidningen; 1969 Jun; 66():Suppl II:44+. PubMed ID: 5384122
    [No Abstract]   [Full Text] [Related]  

  • 77. Age: a growing P & T concern.
    Lipman AG
    Hosp Formul; 1983 May; 18(5):475. PubMed ID: 10260197
    [No Abstract]   [Full Text] [Related]  

  • 78. Developing an effective P & T Committee, Part 2.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rational drug use (II): Hospital drug and therapeutics committees.
    Manyemba J; Dzuda C; Nyazema NZ
    Cent Afr J Med; 2000 Sep; 46(9):256-9. PubMed ID: 11320773
    [No Abstract]   [Full Text] [Related]  

  • 80. The economics of lipid management.
    Mullins CD
    Manag Care; 2001 Nov; 10(11 Suppl):17-8; discussion 19-24. PubMed ID: 11761626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.